6OHQ
Structure of compound 4 bound human Phospholipase D2 catalytic domain
Summary for 6OHQ
Entry DOI | 10.2210/pdb6ohq/pdb |
Descriptor | Phospholipase D2, 4-fluoro-N-{(2S)-1-[4-(2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidin-1-yl]propan-2-yl}benzamide, SULFATE ION, ... (4 entities in total) |
Functional Keywords | phosphodiesterase, hydrolase, hkd motif, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor |
Biological source | Homo sapiens (Human) |
Total number of polymer chains | 2 |
Total formula weight | 148791.99 |
Authors | Metrick, C.M.,Chodaparambil, J.V. (deposition date: 2019-04-06, release date: 2020-02-19, Last modification date: 2023-10-11) |
Primary citation | Metrick, C.M.,Peterson, E.A.,Santoro, J.C.,Enyedy, I.J.,Murugan, P.,Chen, T.,Michelsen, K.,Cullivan, M.,Spilker, K.A.,Kumar, P.R.,May-Dracka, T.L.,Chodaparambil, J.V. Human PLD structures enable drug design and characterization of isoenzyme selectivity. Nat.Chem.Biol., 16:391-399, 2020 Cited by PubMed: 32042197DOI: 10.1038/s41589-019-0458-4 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.694 Å) |
Structure validation
Download full validation report